No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Saturday, June 6, 2026
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Markets

FedEx reports higher Q2 revenue and adj. earnings; EPS beats estimates

by TheAdviserMagazine
6 months ago
in Markets
Reading Time: 2 mins read
A A
FedEx reports higher Q2 revenue and adj. earnings; EPS beats estimates
Share on FacebookShare on TwitterShare on LInkedIn


Cargo giant FedEx Corp. (NYSE: FDX) has reported an increase in revenues and adjusted earnings for the second quarter of fiscal 2026. The numbers also beat analysts’ estimates.

FedEx reports higher Q2 revenue and adj. earnings; EPS beats estimates

Adjusted earnings increased to $4.82 per share in Q2 from $4.05 per share in the year-ago quarter, exceeding Wall Street’s expectations. On a reported basis, net income was $956 million or $4.04 per share in the November quarter, compared to $741 million or $3.03 per share in Q2 2025.

Total revenues came in at $23.5 billion in the second quarter, compared to $22.0 billion in the same quarter a year ago. For fiscal 2026, the company expects revenues to grow 5-6% year-over-year. The guidance for unadjusted earnings per share for FY26 is $14.80 to $16.00, while adjusted earnings are expected to be in the range of $17.80 per share to $19.0 per share.

“FedEx delivered an outstanding second quarter as we successfully executed our growth strategy and advanced our network transformation, while navigating a highly challenging external environment,” said FedEx CEO Raj Subramaniam.



Source link

Tags: BeatsearningsEPSestimatesFedExhigherReportsRevenue
ShareTweetShare
Previous Post

Ethnic Cleansing, Trump Style: Administration Moves to Send Asylum Seekers to Uganda, Honduras and Ecuador

Next Post

Can XGPT’s AI Level The Playing Field For Traders?

Related Posts

edit post
Trump Explores Federal Government Acquiring Shares in AI Companies

Trump Explores Federal Government Acquiring Shares in AI Companies

by TheAdviserMagazine
June 5, 2026
0

WASHINGTON — President Donald Trump said he’s exploring having the federal government acquire shares in artificial intelligence companies, likening the...

edit post
Cboe (CBOE) Has a Data-and-Clearing Engine That Looks Better Than a Volatility Trade

Cboe (CBOE) Has a Data-and-Clearing Engine That Looks Better Than a Volatility Trade

by TheAdviserMagazine
June 5, 2026
0

Cboe (CBOE) is easy to misread because its business sits so close to market activity. When volumes spike, the stock...

edit post
Hot jobs report puts Fed cuts further out of reach as Chair Warsh faces policy tests

Hot jobs report puts Fed cuts further out of reach as Chair Warsh faces policy tests

by TheAdviserMagazine
June 5, 2026
0

New Chairman of the Federal Reserve Kevin Warsh arrives during a swearing in ceremony in the East Room of the...

edit post
Crypto mutiny on Strategy: Shorts target ‘MSTR’ in bitcoin bloodbath

Crypto mutiny on Strategy: Shorts target ‘MSTR’ in bitcoin bloodbath

by TheAdviserMagazine
June 5, 2026
0

Options traders are storming into bets against crypto's most vocal evangelist Michael Saylor. Call it mutiny on Strategy.Flows around Saylor's...

edit post
TransDigm (TDG) Still Has an Aftermarket-and-Pricing Engine That Looks Stronger Than the Leverage Debate

TransDigm (TDG) Still Has an Aftermarket-and-Pricing Engine That Looks Stronger Than the Leverage Debate

by TheAdviserMagazine
June 5, 2026
0

TransDigm (TDG) is often framed as a leveraged aerospace supplier whose upside depends mainly on air-travel demand. That view misses...

edit post
The World Is Growing a Nervous System

The World Is Growing a Nervous System

by TheAdviserMagazine
June 5, 2026
0

Last week, I wrote about the growing push toward “smart wearables” and the idea that AI could become an “always...

Next Post
edit post
Can XGPT’s AI Level The Playing Field For Traders?

Can XGPT’s AI Level The Playing Field For Traders?

edit post
Home Prices and Sales Fall. Can Sellers Count on Lower Interest Rates?

Home Prices and Sales Fall. Can Sellers Count on Lower Interest Rates?

  • Trending
  • Comments
  • Latest
edit post
Supreme Court Delivers More Bad Redistricting News for Democrats

Supreme Court Delivers More Bad Redistricting News for Democrats

May 19, 2026
edit post
From Maine to Michigan, Democrats Are Making Communism Great Again

From Maine to Michigan, Democrats Are Making Communism Great Again

May 16, 2026
edit post
It’s Time To Talk About Massie

It’s Time To Talk About Massie

May 23, 2026
edit post
Red Snapper Used as Cudgel by Fed Judge

Red Snapper Used as Cudgel by Fed Judge

May 31, 2026
edit post
10 Cheapest High Dividend Stocks With P/E Ratios Under 10

10 Cheapest High Dividend Stocks With P/E Ratios Under 10

April 13, 2026
edit post
Health insurers are exiting the Marketplace again. Should consumers be worried?

Health insurers are exiting the Marketplace again. Should consumers be worried?

May 27, 2026
edit post
Want In On SpaceX? Kraken Unveils Early IPO Access Via xStocks

Want In On SpaceX? Kraken Unveils Early IPO Access Via xStocks

0
edit post
5 Reasons Every Woman Needs a Bone-Density Test After 65

5 Reasons Every Woman Needs a Bone-Density Test After 65

0
edit post
Novo’s Wegovy Pill Isn’t Just Beating Expectations — It’s Obliterating Them. Is the Beaten-Down Stock a Buy Now?

Novo’s Wegovy Pill Isn’t Just Beating Expectations — It’s Obliterating Them. Is the Beaten-Down Stock a Buy Now?

0
edit post
What Is Driving Expansion in the Digital Breast Tomosynthesis Market?

What Is Driving Expansion in the Digital Breast Tomosynthesis Market?

0
edit post
CFPs earn 11% more than other financial planners: Compensation study

CFPs earn 11% more than other financial planners: Compensation study

0
edit post
Govt to tap AI for mapping supply chains and investment clusters

Govt to tap AI for mapping supply chains and investment clusters

0
edit post
Novo’s Wegovy Pill Isn’t Just Beating Expectations — It’s Obliterating Them. Is the Beaten-Down Stock a Buy Now?

Novo’s Wegovy Pill Isn’t Just Beating Expectations — It’s Obliterating Them. Is the Beaten-Down Stock a Buy Now?

June 6, 2026
edit post
Want In On SpaceX? Kraken Unveils Early IPO Access Via xStocks

Want In On SpaceX? Kraken Unveils Early IPO Access Via xStocks

June 6, 2026
edit post
5 Reasons Every Woman Needs a Bone-Density Test After 65

5 Reasons Every Woman Needs a Bone-Density Test After 65

June 6, 2026
edit post
Gen Z is ditching college for ‘more secure’ trade jobs—but these rank among worst entry-level jobs

Gen Z is ditching college for ‘more secure’ trade jobs—but these rank among worst entry-level jobs

June 6, 2026
edit post
Michael Hudson: Geopathology and the Econopathology Behind it

Michael Hudson: Geopathology and the Econopathology Behind it

June 6, 2026
edit post
High on Health: Study Says Vaping Can Alter Genes Linked to Cancer

High on Health: Study Says Vaping Can Alter Genes Linked to Cancer

June 6, 2026
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Novo’s Wegovy Pill Isn’t Just Beating Expectations — It’s Obliterating Them. Is the Beaten-Down Stock a Buy Now?
  • Want In On SpaceX? Kraken Unveils Early IPO Access Via xStocks
  • 5 Reasons Every Woman Needs a Bone-Density Test After 65
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.